Cardiac Rhythm Management
banner HRS 2018 SPAF


Activity Description
The webcast is comprised of proceedings from the Heart Rhythm 2018 symposium, Stroke Prevention in Atrial Fibrillation: Advancements in Oral Anticoagulation Therapy and LAA Closure

Cardiac Rhythm Management

Access Presentations

Complimentary Access
We are pleased to provide complimentary and unlimited access to the on-demand video library from SPAF 2018.

To view, click on the presentation titles listed below.

Opening Remarks
Vivek Reddy

Session I
Watchman Implantation – 1
Moderators: Daniel Lustgarten and Boris Schmidt

Watchman Implantation: Tips and Tricks
Douglas Gibson

Pericardial Effusion: Incidence, Timing & Management
Christopher Ellis

Mortality and Net Clinical Benefit: New Analyses from the Watchman RCTs
William Whang

Watchman Implantation: Recorded Case
Operator: Shephal Doshi
Panel: Douglas Gibson, Christopher Ellis, William Whang and Jamie Kim

Session II
AF-Related Stroke & Anticoagulation - 1
Moderators: Jonathan Halperin and John Camm

NOAC Use in “Special Populations”: CKD, Liver Disease, Obesity, Elderly
Jeremy Ruskin

Using NOAC Reversal Agents: When and How?
Elaine Hylek

Understanding Intracranial Hemorrhage Risk before It Happens
Edip Gurol

Non-Cardioembolic Stroke: Incidence in AF Patients& Prevention (OACs vs Antiplatelets)
Jonathan Halperin

Real-World Registry NOAC Outcomes: Relative Effectiveness & Compliance
Luigi Di Biase

Panel Discussion
Panel: John Camm, Jeremy Ruskin, Elaine Hylek, Edip Gurol, Jonathan Halperin and Luigi DiBiase

Session III
LAA Closure Clinical Outcomes
Moderators: Moussa Mansour and Vijay Swarup

Watchman Clinical Trial Update
Oussama Wazni

Update on Amulet Clinical Trials
Boris Schmidt

AtriClip: Recorded Case & Outcomes
Gan Dunnington

LAAC Device Potpourri (Wavecrest / Lambre): What Would the Ideal Device Look Like?
Andrea Natale

Panel Discussion
Panel: Moussa Mansour, Vijay Swarup, Oussama Wazni, Boris Schmidt,
Gan Dunnington and Andrea Natale

Session IV
AF-Related Stroke & Anticoagulation - 2
Moderators: Daniel Lustgarten and Jeremy Ruskin

AF & CAD: Dual vs Triple Therapy in the NOAC Era
John Camm

Subclinical Atrial Fibrillation: Incidence and Management
Taya Glotzer

Identifying AF with Consumer Devices: Hope or Hype?
Mintu Turakhia

MR Imaging for Risk Stratification of Stroke in AF
Benjamin Steinberg

ILRs to Identify AF in High-Risk Individuals: Insights from REVEAL AF
Atul Verma

Panel Discussion
Panel: Daniel Lustgarten, Jeremy Ruskin, John Camm, Mintu Turakhia, Benjamin Steinberg and Atul Verma

Session V
Watchman Implantation -2:
The Next-Gen Device – Watchman-Flex

Moderators: Vivek Reddy and Douglas Gibson

Peri-Device Leaks: Incidence, Outcomes & Management
Sheldon Singh

Coil Embolization of Peri-Device Leaks: Technique and Results
Rodney Horton

Device-Related Thrombus: Incidence, Management & Outcomes
Lucas Boersma

Watchman-Flex Implantation: Recorded Case
Operator: Srinivas Dukkipati
Panel: Sheldon Singh, Rodney Horton, Lucas Boersma and Shephal Doshi

Session VI
LAA Closure: Avoiding & Managing Complications
Moderator: Daniel Lustgarten

LAAC Device Embolization – Incidence, Outcomes, Management
Dhanunjaya Lakkireddy

An Unusual Case: Late Removal of a Malpositioned LAAC Device
Petr Neuzil

Minimizing Device-Related Thrombus: Strategies to Consider
Vijay Swarup

LAAC Strategies in the Patient with an Active LAA Thrombus
Vivek Reddy

Late Stroke after LAAC: How do I evaluate the Patient?
Edip Gurol

Panel Discussion
Panel: Daniel Lustgarten, Luigi DiBiase, Dhanunjaya Lakkireddy, Petr Neuzil, Vijay Swarup, Vivek Reddy and Edip Gurol

Session VII
Advancing the Clinical Science of LAA Closure
Moderators: Andre d'Avila and Oussama Wazni

Multicenter LAAC RCTs: Ongoing Trials & What is Needed?
Thorsten Lewalter

Stroke Prevention Trial Endpoints: What are both persuasive and practical?
Douglas Packer

LAAC in Contraindicated Patients
Jonathan Hsu

Initial Outcomes from the NCDR LAAC Registry
Paul Varosy

Outcomes of Surgical LAAC: What is known? What will LAAOS III tell us?
Jonathan Piccini

Panel Discussion
Panel: Andre d'Avila, Oussama Wazni, Thorsten Lewalter, Douglas Packer, Jonathan Hsu, Paul Varosy and Jonathan Piccini

Session VIII
LAA Potpourri
Moderators: Jamie Kim and Douglas Packer

Percutaneous Carotid Coil Filters: A Novel Approach to Stroke Prevention?
Vivek Reddy

Combining LAAC with AF Ablation
Moussa Mansour

Combining LAAC with Percutaneous Valve Procedures
Samir Kapadia

Panel Discussion
Panel: Jamie Kim, Douglas Packer, Vivek Reddy, Moussa Mansour, and Samir Kapadia




Program Chair

Vivek Reddy, MD
The Mount Sinai Hospital
New York, NY



Lucas Boersma, MD, PhD
St. Antonius Hospital
Nieuwegein, The Netherlands

John Camm, MD
St. George’s University of London
London, England

Andre d'Avila
Hospital SOS Cardio
Florianópolis, Brazil

Luigi Di Biase, MD, PhD
Montefiore Medical Center/Albert Einstein College of Medicine
Bronx, NY

Shephal Doshi, MD
Pacific Heart Institute
Santa Monica, CA

Srinivas Dukkipati, MD
The Mount Sinai Hospital
New York, NY

Gan Dunnington, MD
St. Helena Arrhythmia Center
St. Helena, CA

Christopher Ellis, MD
Vanderbilt Heart and Vascular Institute
Nashville, TN

Douglas Gibson, MD
Scripps Green Hospital
La Jolla, CA

Taya Glotzer, MD
Hackensack University Medical Center
Hackensack, NJ

Edip Gurol, MD
Massachusetts General Hospital
Boston, MA

Jonathan Halperin, MD
The Mount Sinai Hospital
New York, NY

Rodney Horton, MD
Texas Cardiac Arrhythmia Institute
Austin, TX

Jonathan Hsu, MD
University of California, San Diego
La Jolla, CA

Elaine Hylek, MD
Boston University School of Medicine
Boston, MA

Samir Kapadia, MD
Cleveland Clinic
Cleveland, OH

Jamie Kim, MD, FACC
New England Heart & Vascular Institute
Manchester, NH

Dhanunjaya Lakkireddy, MD
Overland Park Regional Medical Center
Overland Park, KS


Thorsten Lewalter, MD
Peter Osypka Heart Center Munich
Munich, Germany

Daniel Lustgarten, MD
University of Vermont Health Network
Burlington, VT

Moussa Mansour, MD
Massachusetts General Hospital
Boston, MA

Andrea Natale, MD
Texas Cardiac Arrhythmia Institute
Austin, TX

Petr Neuzil, MD, PhD
Homnolka Hospital
Prague, Czech Republic

Douglas Packer, MD
Mayo Clinic
Rochester, MN

Jonathan Piccini, MD
Duke University Medical Center
Durham, NC

Jeremy Ruskin, MD
Massachusetts General Hospital
Boston, MA

Boris Schmidt, MD
Cardioangiologisches Centrum Bethanien
Frankfurt, Germany

Sheldon Singh, MD
Sunnybrook Health Sciences Center
Toronto, Canada

Vijay Swarup, MD, FACC, FHRS
Arizona Heart Rhythm Institute
Phoenix, AZ

Mintu Turakhia, MD
Stanford University and Palo Alto VA
Health Care System
Palo Alto, CA

Paul Varosy, MD
VA Eastern Colorado Health Care System
Denver, CO

Atul Verma, MD
Southlake Regional Health Centre
Newmarket, Ontario, Canada

Oussama Wazni, MD
Cleveland Clinic
Cleveland, OH

William Whang, MD
The Mount Sinai Hospital
New York, NY






Activity Description
This on-demand webcast was created from the proceedings of the Symposium on Stroke Prevention in Atrial Fibrillation: Advancements in Oral Anticoagulation Therapy and LAA Closure. This activity features world-renowned faculty experts, who explore the most recent advancements and developments in LAAC and oral anticoagulation therapy for managing AF related stroke. The webcast showcases LAAC cases from leading institutions, insightful rapid-fire presentations, expert panel discussions, and engaging Q&A sessions.

Target Audience
This activity has been developed to meet the educational needs of electrophysiologists, interventional cardiologists, cardiologists, surgeons, and other physicians and associated healthcare professionals with an interest in the management of stroke in AF patients.

Learning Objectives
Upon completion of this educational activity, participants will be able to:

  • Identify how to use and reverse NOACs.
  • Discuss the role of the Left Atrial Appendage (LAA) in AF-related strokes.
  • Evaluate novel oral anticoagulation and advancements in Left Atrial Appendage Closure (LAAC) for stroke prophylaxis in AF.
  • Review strategies for balancing stroke vs bleeding in clinical practice.
  • Examine randomized clinical trial and registry data.
  • Review appropriate NOACC and LAAC patient selection criteria.
  • Assess the cost-effectiveness, efficacy and safety of LAAC therapy.
  • Evaluate optimal LAAC clinical decision making strategies and procedural approaches.
  • Examine catheter ablation with LAAC, including patient selection, clinical workflow and outcomes.
  • Assess clinical outcomes and practical aspects of LACC.




logo abbott web

logo AtriCure

logo biosense web color

logo BSCI web

logo medtronic


Course Organizer
mediasphere medical logo


SPAF 2017

On-Demand Video Presentations from 2017 SPAF

Complimentary Access
We are pleased to provide complimentary and unlimited access to the on-demand video library from the 2017 Symposium on Stroke Prevention in Atrial Fibrillation Advancements in Oral Anticoagulation Therapy and LAA Closure. The presentation format consists of synched audio and video, along with the presenters slides.

Access 2017 Live Cases and presentations

Click Here >>


tmb spaf17 vivek tmb spaf17 livecase tmb spaf17 panel